Day 2 - Industry Summit - 11 February

08:50
09:00

Minister under invitation

09:20
  • Setting the scene – how medicinal cannabis is being used to heal illness?
  • Advocating for equity in access to medicinal cannabis for patients
Bonni Goldstein Medical Director, Canna Centers Wellness & Education
09:50

Research shows that being from New Zealand adds value to your brand, and that provenance matters. This session showcases the strength in brand New Zealand and  

will shed light on the value-adding opportunity for medicinal cannabis. 

  • Using New Zealand’s brand and image in the medicinal cannabis industry – how can we leverage this to increase value? 
  • Coming together and collaborating to advocate for the industry – what is the opportunity here? 
  • A view into the practical tools that the New Zealand Story group have to help 
David Downs Chief Executive Officer, New Zealand Story
10:40
  • The opportunity to develop the CBD sector in New Zealand – what are the resources available to achieve this?
  • Insights into the economic opportunity

11:10
  • Examining how medicinal cannabis can be a big contributing factor to NZ’s economy
  • Callaghan Innovation’s assistance in companies being established in the medicinal cannabis industry
  • Insights on how the roadmap has been developed and how it is evolving with the changing nature of regulations

Simon Yarrow Group Manager, Agrifood, Callaghan Innovation
11:40
  • Explaining the work currently being undertaken by Crown Research Institutes in the medicinal cannabis space
  • Advocating for the industry – a spotlight on the work taking place here

Dr Trevor Stuthridge Research Director, AgResearch
Dr Stefan Hill Portfolio Leader for High-Value Biorefineries, Scion
Dr Richard Newcomb, PhD Chief Scientist, Plant & Food Research
13:20
  • History of veterinary medicinal cannabis
  • The endocannabinoid system in animals
  • Toxicology and the THC myth
  • Evidence for therapeutic use
  • International markets and regulation

Jacob Morrison

13:50
  • The impact and opportunity that disruptive technology has on New Zealand’s primary industry
  • Becoming a data focused cultivator with the use of AI and ML – how can growers make informed decisions using this?
  • Segmenting critical information to capture growth patterns

14:50
Katy Thomas TV Presenter. Editor. Mother And Overnight Influencer
15:20

Martin Lee, Director, Project CBD

10:40
Andrea Eng Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health
10:40
Ali Seyfoddin Associate Professor of Drug Delivery and Biological Engineering Deputy Head of School, School of Science, Auckland University of Technology
10:40
  • Nutrients
  • Grow media
  • Bio pesticides
10:40

What are considerations for the sector?

10:40

What are considerations for the sector?

Richard Keene Principal, KMSL
13:10
Andrea Eng Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health
13:10
Ali Seyfoddin Associate Professor of Drug Delivery and Biological Engineering Deputy Head of School, School of Science, Auckland University of Technology
13:10
  • Nutrients
  • Grow media
  • Bio pesticides
13:10

What are considerations for the sector?

13:10

What are considerations for the sector?

Richard Keene Principal, KMSL